Study protocol of short versus long-term levetiracetam in brain tumors (LIBRA): a phase 3 randomized controlled trial

Abstract Background Seizures are common in patients with brain tumors, impacting daily life and healthcare burden. In contemporary neuro-oncology practice, levetiracetam is the most commonly prescribed anti-seizure medication (ASM). Although the practice is widely variable, levetiracetam is usually...

Full description

Bibliographic Details

Published in:	BMC Cancer
Main Authors:	Archya Dasgupta, Shakthivel Mani, Abhishek Chatterjee, Sadhana Kannan, Aliasgar Moiyadi, Prakash Shetty, Vikas Singh, Nandini Menon, Arpita Sahu, Amitkumar Choudhary, Kajari Bhattacharya, Ameya Puranik, Indraja Dev, Sridhar Epari, Ayushi Sahay, Aekta Shah, Nazia Bano, Farnaz Shaikh, Tejpal Gupta
Format:	Article
Language:	English
Published:	BMC 2025-05-01
Subjects:	Seizures Levetiracetam Brain tumor Antiepileptics Glioma
Online Access:	https://doi.org/10.1186/s12885-025-14305-7